Drug intelligence / Profile preview

HB Vax Pro + Vaqta

Development stage
Unknown
Lead developer
Merck
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

HB Vax Pro + Vaqta is a co-administered vaccine combination used for active immunization against hepatitis A and hepatitis B infections. It consists of two separate vaccines given concomitantly: HB Vax Pro, a recombinant hepatitis B vaccine containing hepatitis B surface antigen (HBsAg) produced in *Saccharomyces cerevisiae* yeast, and Vaqta, an inactivated whole-virus hepatitis A vaccine. Developed by Sanofi Pasteur MSD (now part of MSD), these vaccines are typically administered via intramuscular injection at separate sites. The combination works by stimulating the immune system to produce protective neutralizing antibodies against both the hepatitis A virus and the hepatitis B virus surface antigen, providing comprehensive protection for individuals at risk of exposure to both pathogens.

Brand names
HBVAXPRO + Vaqta
Other names
Hepatitis A and Hepatitis B vaccine combination
02

Targets

HBsAg (Hepatitis B surface antigen)

Beyond the preview

Go deeper on HB Vax Pro + Vaqta.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HB Vax Pro + Vaqta.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call